The Common Registration Assessment's Part 2 is not really testing whether you know what treats what. It is testing whether you can spot the option that would harm this particular patient. The distractors are chosen precisely because they are reasonable: correct drug class, sensible dose, standard therapy, exactly what you would supply nine times out of ten. What makes one of them wrong is a single detail buried in the stem, and candidates who read the stem for the diagnosis rather than for the danger will walk straight past it.
Key takeaways
- Distractors in Part 2 are usually clinically reasonable options made unsafe by one patient-specific factor.
- Read the stem for the danger, not just for the diagnosis, and treat every patient detail as deliberate.
- Screen systematically: contraindications, interactions, renal and hepatic function, age, pregnancy and allergy.
- Separate medicine knowledge from professional judgement, because they fail differently and need different revision.
- When reviewing, ask when the wrong option would have been right, and then change one variable and re-test.
Read for the danger, not the diagnosis
The instinct built by clinical training is to identify the condition and then pick the treatment. Part 2 punishes exactly that reflex, because it usually gives you a straightforward condition with an obvious first-line therapy and then makes that therapy unsafe.
So invert the reading. Once you know what the patient has, do not go to the options. Go back to the stem and ask a different question: what in this patient's circumstances would make a standard answer wrong?
Every clause in a well-written stem is doing work. The age. The weight. The pregnancy. The list of current medicines. The eGFR sitting quietly in a table. The line about a rash after penicillin years ago. None of that is scene-setting. In a paper about safe and effective care, those details are the question.
The screen
Run the same checklist every time, and it will become quick.
Contraindications. Is there anything in this patient that makes the obvious drug flatly inadvisable? Asthma and a non-selective beta blocker. Pregnancy and a teratogen. A history of angioedema.
Interactions. Look at the existing medicines list before you choose. The classic pairs recur because they matter, and prescription review items are built on them.
Renal and hepatic function. A creatinine or an eGFR in a stem is never decoration. It changes the drug, the dose, or the monitoring, and it is one of the most reliable discriminators in the whole paper.
Age. Paediatric and elderly patients change dosing, formulation and the risk profile of the same drug. A dose appropriate for a fit forty-year-old may be reckless in a frail eighty-five-year-old on five other medicines.
Pregnancy and breastfeeding. Changes both what you can supply and what you must advise.
Allergy and previous reaction. And crucially, distinguish a genuine allergy from an intolerance, because the two have different consequences and the exam knows it.
Medicine knowledge and professional judgement fail differently
Part 2 tests two quite separable things, and your errors will cluster in one or the other.
The first is medicine: therapeutics, pharmacology, interactions, monitoring, what to supply. If you are losing marks here, the fix is content revision.
The second is professional judgement: law, governance, ethics, scope, what a pharmacist must do rather than what a medicine does. Whether a supply is legal. Whether you can act on this prescription. What you must record. When to refuse, when to escalate, when to break confidentiality. This is a distinct body of knowledge, and candidates who are strong clinically routinely underperform on it because it does not feel like pharmacy in the way therapeutics does.
Track them separately, because a candidate who cannot recall a controlled drug requirement and one who cannot recall a dose adjustment need entirely different fortnights.
The extended matching trap
Part 2 includes extended matching sets in which two questions share the same list of eight options. The design invites a specific error: matching on pattern.
Having chosen an option for the first question, candidates scan for the option that best fits the second by resemblance rather than working the case fully. The option lists are deliberately populated with plausible near-misses, and a shared list is precisely where a near-miss is most likely to catch you.
Work each case independently. Cover the options if it helps, decide what you think the answer is, and only then look at the list.
Review the option you nearly chose
The most productive habit in Part 2 review takes a minute per question and it is not reading the explanation.
For each item where you hesitated, write down the option you nearly picked, and then write one sentence: not why the correct answer is correct, but when your option would have been correct.
"Trimethoprim would have been right if she were not pregnant." "That dose would have been right if his eGFR were normal." "Supply would have been appropriate if the prescription had been dated within six months."
That sentence is the transferable rule. The correct answer is worth one mark once; the rule is worth marks repeatedly, because the exam will test the same principle with a different drug.
Change one variable and re-test
Finally, prove the rule transferred. Take a question you got wrong, change a single patient variable in your head, and ask whether your answer changes. If the patient were not pregnant, what would you supply? If the eGFR were 80 rather than 25? If she were eighty rather than thirty?
If you can answer those confidently, you have learned a principle. If you can only remember what the model answer said, you have memorised an item, and the next question will catch you.
Where iatroX fits
iatroX's GPhC bank covers Part 2's therapeutics alongside law, governance and professional practice, tracked separately so you can see which of the two failure modes is actually costing you marks. Explanations are grounded in current guidance including the SmPC, so the reason a drug is contraindicated in a specific patient sits with the question, and the adaptive engine returns the interactions, monitoring requirements and regulatory details you keep missing rather than letting them slide. Missed questions can be opened in the Socratic Tutor, which asks you to reason before it explains, which is how you find out whether you understood the principle or merely remembered the answer. Try it with free sample questions at iatroX. For how the two papers demand separate preparation, see Part 1 and Part 2.
Frequently asked questions
Why are GPhC Part 2 questions so hard when I know the therapeutics? Because the distractors are clinically reasonable options made unsafe by one patient-specific factor. The exam tests whether you spot the danger, not whether you know the standard treatment, so reading the stem for the diagnosis alone will lead you into the trap.
What patient details should I always check before answering? Contraindications, current medicines and interactions, renal and hepatic function, age, pregnancy and breastfeeding, and allergy versus intolerance. Any of these in a stem is there deliberately and frequently determines the answer.
Why do I do badly on law and governance questions? Because they test a different competency from therapeutics and are usually under-revised. Clinically strong candidates often neglect them precisely because they do not feel like pharmacy. Track them as a separate domain and revise them separately.
How do I review a Part 2 question properly? Write down the option you nearly chose and the single sentence explaining when it would have been correct. Then change one patient variable and ask whether your answer changes. That tests whether you learned a principle or memorised an item.